These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8202664)
1. Monospecific but not polyreactive human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4. Newkirk MM; Rauch J Rheumatol Int; 1994; 13(5):203-9. PubMed ID: 8202664 [TBL] [Abstract][Full Text] [Related]
2. Restricted immunoglobulin variable region gene usage by hybridoma rheumatoid factors from patients with systemic lupus erythematosus and rheumatoid arthritis. Newkirk MM; Rauch J; Mageed RA; Jefferis R; Posnett DN; Silverman GJ Mol Immunol; 1993 Feb; 30(3):255-63. PubMed ID: 7679467 [TBL] [Abstract][Full Text] [Related]
3. Importance of the IgG isotype, not the state of glycosylation, in determining human rheumatoid factor binding. Newkirk MM; Lemmo A; Rauch J Arthritis Rheum; 1990 Jun; 33(6):800-9. PubMed ID: 2363735 [TBL] [Abstract][Full Text] [Related]
4. Mapping IgG epitopes bound by rheumatoid factors from immunized controls identifies disease-specific rheumatoid factors produced by patients with rheumatoid arthritis. Bonagura VR; Agostino N; Børretzen M; Thompson KM; Natvig JB; Morrison SL J Immunol; 1998 Mar; 160(5):2496-505. PubMed ID: 9498795 [TBL] [Abstract][Full Text] [Related]
5. Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients. Rauch J; Massicotte H; Tannenbaum H J Immunol; 1985 Oct; 135(4):2385-92. PubMed ID: 3875652 [TBL] [Abstract][Full Text] [Related]
6. Binding specificities of a polyreactive and a monoreactive human monoclonal IgG rheumatoid factor: role of oligosaccharides. al-Balaghi S; Abedi-Valugerdi M; Möller E Scand J Immunol; 1996 Nov; 44(5):470-7. PubMed ID: 8947598 [TBL] [Abstract][Full Text] [Related]
7. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis. Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764 [TBL] [Abstract][Full Text] [Related]
8. The specificity of synovial IgM rheumatoid factors (RF) for genetically engineered IgG antibodies is not affected by the method used to immortalize RF-producing B cells. Bonagura VR; Kwong T; Kenny T; Robbins DL; Morrison SL Scand J Immunol; 1999 Jan; 49(1):106-11. PubMed ID: 10023865 [TBL] [Abstract][Full Text] [Related]
18. Reaction of rheumatoid factors with IgG3 monoclonal anti-Rh(D) antibodies: more frequent reactivity to a monoclonal antibody of the Gm allotype G3m(5) in rheumatoid patients negative for G3m(5). Puttick AH; Williamson EA; Merry AH; Kumpel BM; Thompson KM; Jones VE Ann Rheum Dis; 1988 Nov; 47(11):898-905. PubMed ID: 3207373 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of Clq binding activity by IgM rheumatoid factor. Zilberfarb JL; Andrews BS; Young AC; Davis JS J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433 [TBL] [Abstract][Full Text] [Related]
20. A new assay for IgG rheumatoid factor activity and its use to analyse rheumatoid factor reactivity with human IgG isotypes. Elson CJ; Carter SD; Scott DG; Bacon PA; Lowe J Rheumatol Int; 1985; 5(4):175-9. PubMed ID: 4048759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]